{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:48:37Z","timestamp":1791413317883,"version":"4.3.3"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1124\/mol.110.064261","type":"journal-article","created":{"date-parts":[[2010,5,14]],"date-time":"2010-05-14T01:10:08Z","timestamp":1273799408000},"page":"319-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["A Small-Molecule Oxocarbazate Inhibitor of Human Cathepsin L Blocks Severe Acute Respiratory Syndrome and Ebola Pseudotype Virus Infection into Human Embryonic Kidney 293T cells"],"prefix":"10.1016","volume":"78","author":[{"given":"Parag P.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Kaletsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy E.","family":"Purvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyan","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Huryn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron C.","family":"Greenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Amos B.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.110.064261_bib1","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1021\/ci800085c","article-title":"Molecular docking of cathepsin L inhibitors in the binding site of papain","volume":"48","author":"Beavers","year":"2008","journal-title":"J Chem Inf Model"},{"key":"10.1124\/mol.110.064261_bib2","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science"},{"key":"10.1124\/mol.110.064261_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev.physiol.59.1.63","article-title":"Emerging roles for cysteine proteases in human biology","volume":"59","author":"Chapman","year":"1997","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/mol.110.064261_bib4","series-title":"Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists.","author":"Copeland","year":"2005"},{"key":"10.1124\/mol.110.064261_bib5","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.302.5653.2045","article-title":"Breakthrough of the year. SARS: a pandemic prevented","volume":"302","author":"Enserink","year":"2003","journal-title":"Science"},{"key":"10.1124\/mol.110.064261_bib6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nri1154","article-title":"Ebola virus: from discovery to vaccine","volume":"3","author":"Feldmann","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/mol.110.064261_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1074-5521(00)00014-4","article-title":"Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools","volume":"7","author":"Greenbaum","year":"2000","journal-title":"Chem Biol"},{"key":"10.1124\/mol.110.064261_bib8","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1126\/science.1077426","article-title":"A role for the protease falcipain 1 in host cell invasion by the human malaria parasite","volume":"298","author":"Greenbaum","year":"2002","journal-title":"Science"},{"key":"10.1124\/mol.110.064261_bib9","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1074\/jbc.M508381200","article-title":"SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells","volume":"281","author":"Huang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.064261_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-1280(01)00682-0","article-title":"The acidities of some indoles","volume":"583","author":"Hur","year":"2002","journal-title":"J Mol Struct Theochem"},{"key":"10.1124\/mol.110.064261_bib11","doi-asserted-by":"crossref","first-page":"13378","DOI":"10.1128\/JVI.01170-07","article-title":"Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity","volume":"81","author":"Kaletsky","year":"2007","journal-title":"J Virol"},{"key":"10.1124\/mol.110.064261_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"10.1124\/mol.110.064261_bib13","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1172\/JCI25485","article-title":"Cathepsin L is essential for onset of autoimmune diabetes in NOD mice","volume":"115","author":"Maehr","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.110.064261_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.biophys.28.1.181","article-title":"The lysosomal cysteine proteases","volume":"28","author":"McGrath","year":"1999","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"10.1124\/mol.110.064261_bib15","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1016\/j.bmcl.2008.04.065","article-title":"Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype","volume":"18","author":"Myers","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.110.064261_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bmcl.2007.10.107","article-title":"Identification and synthesis of a unique thiocarbazate cathepsin L inhibitor","volume":"18","author":"Myers","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.110.064261_bib17","doi-asserted-by":"crossref","first-page":"12714","DOI":"10.1128\/JVI.79.20.12714-12720.2005","article-title":"Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein","volume":"79","author":"Pager","year":"2005","journal-title":"J Virol"},{"key":"10.1124\/mol.110.064261_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2007.10.011","article-title":"Cysteine cathepsin proteases as pharmacological targets in cancer","volume":"29","author":"Palermo","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.110.064261_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.0959-9673.2004.00373.x","article-title":"Cathepsin L-deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy","volume":"85","author":"Potts","year":"2004","journal-title":"Int J Exp Pathol"},{"key":"10.1124\/mol.110.064261_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1515\/BC.2004.040","article-title":"Comprehensive search for cysteine cathepsins in the human genome","volume":"385","author":"Rossi","year":"2004","journal-title":"Biol Chem"},{"key":"10.1124\/mol.110.064261_bib21","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/sj.gt.3302265","article-title":"Targeting cathepsin L (CL) by specific ribozymes decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis","volume":"11","author":"Schedel","year":"2004","journal-title":"Gene Ther"},{"key":"10.1124\/mol.110.064261_bib22","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/JVI.80.8.4174-4178.2006","article-title":"Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein","volume":"80","author":"Schornberg","year":"2006","journal-title":"J Virol"},{"key":"10.1124\/mol.110.064261_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/mol.108.046219","article-title":"Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L","volume":"74","author":"Shah","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.110.064261_bib24","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1073\/pnas.0505577102","article-title":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry","volume":"102","author":"Simmons","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.064261_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1107\/S0907444902021479","article-title":"Lysosomal cysteine proteases (cathepsins): promising drug targets","volume":"59","author":"Turk","year":"2003","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/mol.110.064261_bib26","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1093\/emboj\/20.17.4629","article-title":"Lysosomal cysteine proteases: facts and opportunities","volume":"20","author":"Turk","year":"2001","journal-title":"EMBO J"},{"key":"10.1124\/mol.110.064261_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/138161207780162962","article-title":"Emerging roles of cysteine cathepsins in disease and their potential as drug targets","volume":"13","author":"Vasiljeva","year":"2007","journal-title":"Curr Pharm Des"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24027445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24027445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.110.064261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:46:38Z","timestamp":1739958398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24027445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0026895X24027445"],"URL":"https:\/\/doi.org\/10.1124\/mol.110.064261","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Small-Molecule Oxocarbazate Inhibitor of Human Cathepsin L Blocks Severe Acute Respiratory Syndrome and Ebola Pseudotype Virus Infection into Human Embryonic Kidney 293T cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.110.064261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}